SMS Pharmaceuticals Limited (NSE:SMSPHARMA)
India flag India · Delayed Price · Currency is INR
523.00
+9.80 (1.91%)
Nov 11, 2026, 1:30 PM IST

SMS Pharmaceuticals Cash Flow Statement

Millions INR. Fiscal year is Apr - Mar.

Operating Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Net Income
1,1691,020691.36498.26-70.59622.2
Depreciation & Amortization
404.19397.59342.16314.67320.72320.93
Other Amortization
3.853.812.682.052.22.51
Loss (Gain) From Sale of Assets
0--0.21-0.370.54-0.02
Loss (Gain) From Sale of Investments
-1.93-5.469.752.252.011.56
Other Operating Activities
109.98116.27202.13229.88282.5287.18
Change in Accounts Receivable
-218.69-126.33330-878.47-998.27571.61
Change in Inventory
-602.74-664.77-510.31-101.98275.98-1,133
Change in Accounts Payable
307.365.17-374.06438.68424.3774.18
Change in Income Taxes
-8.31-8.3115.3443.0632.91-14.58
Change in Other Net Operating Assets
63.47-205.62108.26-46.77-47.89-81.85
Operating Cash Flow
1,227592.24817.09501.25224.5450.6
Operating Cash Flow Growth
62.75%-27.52%63.01%123.27%-50.18%-50.19%

Investing Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Capital Expenditures
-1,868-1,306-1,234-521.6-299.21-272.47
Sale of Property, Plant & Equipment
0.1-0.560.882.630.17
Investment in Securities
-0.05-0.04-0.15-0.07-1.68-
Other Investing Activities
10.5-2.18-0.90.070.690.77
Investing Cash Flow
-1,857-1,308-1,234-520.72-297.56-271.53

Financing Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Short-Term Debt Issued
-261.05108.03202.07258.778.89
Long-Term Debt Issued
-623.19637.24450.8694.14451.9
Total Debt Issued
633.39884.24745.27652.93352.91460.79
Short-Term Debt Repaid
------38.35
Long-Term Debt Repaid
--343.52-447.99-388.01-437.93-337.45
Lease Payments
---7.02-10.37-7.35-9.09
Total Debt Repaid
-383.9-343.52-447.99-388.01-437.93-375.8
Net Debt Issued (Repaid)
249.49540.72297.28264.92-85.0284.99
Common Dividends Paid
-37.46-35.46-33.86-25.4-25.4-25.4
Other Financing Activities
-215.21255.09207.3767.26-209.28-177.06
Financing Cash Flow
-3.18760.35470.79306.79-319.69-117.47

Net Cash Flow

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Net Cash Flow
-633.7844.7853.6287.32-392.7561.6

Free Cash Flow

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Free Cash Flow
-641.15-713.35-416.71-20.35-74.71178.12
Free Cash Flow Growth
------
Free Cash Flow Margin
-6.58%-8.03%-5.32%-0.29%-1.43%3.43%
Free Cash Flow Per Share
-6.85-7.80-4.92-0.24-0.882.10
Levered Free Cash Flow
-1,080-931.16-694.83-252.73-316-224.79
Unlevered Free Cash Flow
-945.8-795.14-587.33-112.92-186.46-113.22
Free Cash Flow After Leases
-641.15-713.35-423.73-30.73-82.05169.04

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash Interest Paid
221.12221.12173.53217.52209.28177.06
Cash Income Tax Paid
241241198.3315446149.2
Change in Working Capital
-458.97-939.86-430.78-545.48-312.89-583.75